Walmart settles US opioid lawsuit for US$50 million
Walmart will pay US$50 million to settle a US Department of Justice lawsuit accusing the retailer of fuelling the nationwide opioid epidemic by failing to report suspicious prescriptions from its pharmacies.
Source: The Business Times Singapore · August 29, 2026 at 10:19 AM · AI-assisted report
Single-source.svg%2F1280px-Walmart_spark_(2025).svg.png%3Futm_source%3Den.wikipedia.org%26utm_campaign%3Dapi%26utm_content%3Dthumbnail&w=1280&output=webp&q=78&sharp=1&con=3&sat=3&we)
UNITED STATES, WILMINGTON, DELAWARE, 29 AUGUST 2026 —
Walmart will pay US$50 million to settle a US Department of Justice lawsuit accusing the retailer of fuelling the nationwide opioid epidemic by failing to report suspicious prescriptions from its pharmacies.
Market Impact
The payout is far below the billions of dollars in civil penalties the Justice Department had said Walmart could owe when the lawsuit began in December 2020.
Walmart did not admit liability and called the settlement amount “immaterial” in a regulatory filing. The company reported net income of US$11.7 billion for the six months to July 31, up from US$10.1 billion in the same period a year earlier.
The Justice Department had alleged Walmart violated the federal Controlled Substances Act since 2013 by repeatedly missing “red flags” in opioid prescriptions. It claimed some compliance officials knew certain prescribers operated as “pill mills” yet continued filling their orders. The lawsuit was one of the department’s most significant cases against a single company over the opioid crisis.
Under the settlement, Walmart will tighten oversight of its pharmacists and establish a hotline for employees and patients to report suspected illegal dispensing of painkillers.
“Today’s settlement proves this department is committed to putting Americans’ flourishing first,” Associate Attorney General Stanley Woodward said in a statement.
Walmart’s settlement follows a US$3.1 billion agreement in 2022 to resolve thousands of lawsuits by state and local governments over its pharmacies’ role in the crisis. CVS and Walgreens reached similar, larger settlements.
More than 905,000 people in the US died from opioid overdoses between 1999 and 2025, according to the US Centres for Disease Control and Prevention. The agency said annual deaths began declining after 2022.
Walmart said in a statement it was pleased to resolve the matter and would continue supporting its pharmacists’ patient care. A joint stipulation to dismiss the case was filed on Thursday in federal court in Wilmington, Delaware.
Walmart shares closed up 46 cents at US$103.09 on Friday.
The lawsuit originally included four claims. In March 2024, US District Judge Colm Connolly dismissed two: that Walmart failed to report suspicious prescriptions to the US Drug Enforcement Administration and that its pharmacists failed to document red flags. Two claims remained: that Walmart compliance personnel knew prescriptions were invalid and that pharmacists dispensed them anyway.
Other companies targeted over opioids included Purdue Pharma, which pleaded guilty to criminal charges in 2020 related to OxyContin and later filed for bankruptcy protection, and drug wholesaler Cencora, formerly AmerisourceBergen.
Related: Walmart Inc. · Stanley Woodward